BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9721172)

  • 1. Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child.
    Srivastava M; Perez-Atayde A; Jonas MM
    Gastroenterology; 1998 Sep; 115(3):743-6. PubMed ID: 9721172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute vanishing bile duct syndrome after ibuprofen therapy in a child.
    Taghian M; Tran TA; Bresson-Hadni S; Menget A; Felix S; Jacquemin E
    J Pediatr; 2004 Aug; 145(2):273-6. PubMed ID: 15289784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man.
    Juricic D; Hrstic I; Radic D; Skegro M; Coric M; Vucelic B; Francetic I
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):62-5. PubMed ID: 19906050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus.
    Okan G; Yaylaci S; Peker O; Kaymakoglu S; Saruc M
    World J Gastroenterol; 2008 Aug; 14(29):4697-700. PubMed ID: 18698687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of early immunosuppressive therapy in a child with carbamazepine-associated vanishing bile duct and Stevens-Johnson syndromes.
    Garcia M; Mhanna MJ; Chung-Park MJ; Davis PH; Srivastava MD
    Dig Dis Sci; 2002 Jan; 47(1):177-82. PubMed ID: 11837721
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute vanishing bile duct syndrome after the use of ibuprofen.
    Basturk A; Artan R; Yılmaz A; Gelen MT; Duman O
    Arab J Gastroenterol; 2016 Sep; 17(3):137-139. PubMed ID: 27658326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibuprofen associated acute vanishing bile duct syndrome and toxic epidermal necrolysis in an infant.
    Kim HY; Yang HK; Kim SH; Park JH
    Yonsei Med J; 2014 May; 55(3):834-7. PubMed ID: 24719156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic cholestasis, paucity of bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An ampicillin-associated case.
    Cavanzo FJ; Garcia CF; Botero RC
    Gastroenterology; 1990 Sep; 99(3):854-6. PubMed ID: 2116345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced vanishing bile duct syndrome: response to ursodiol.
    O'Brien CB; Shields DS; Saul SH; Reddy KR
    Am J Gastroenterol; 1996 Jul; 91(7):1456-7. PubMed ID: 8678017
    [No Abstract]   [Full Text] [Related]  

  • 11. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
    Pusl T; Beuers U
    World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis.
    Lin WC; Hsieh TS; Chu CY
    Front Med (Lausanne); 2022; 9():975754. PubMed ID: 36353223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile duct disorders.
    Geubel AP; Sempoux C; Rahier J
    Clin Liver Dis; 2003 May; 7(2):295-309. PubMed ID: 12879985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis.
    White JC; Appleman S
    Pediatrics; 2014 Oct; 134(4):e1194-8. PubMed ID: 25246624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens-Johnson syndrome and acute vanishing bile duct syndrome after the use of amoxicillin and naproxen in a child.
    Li L; Zheng S; Chen Y
    J Int Med Res; 2019 Sep; 47(9):4537-4543. PubMed ID: 31448655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms.
    Karnsakul W; Arkachaisri T; Atisook K; Wisuthsarewong W; Sattawatthamrong Y; Aanpreung P
    Ann Hepatol; 2006; 5(2):116-9. PubMed ID: 16807519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid.
    Smith LA; Ignacio JR; Winesett MP; Kaiser GC; Lacson AG; Gilbert-Barness E; González-Peralta RP; Wilsey MJ
    J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):469-73. PubMed ID: 16205517
    [No Abstract]   [Full Text] [Related]  

  • 18. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
    Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
    Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanishing bile duct syndrome temporally associated with ibuprofen use.
    Alam I; Ferrell LD; Bass NM
    Am J Gastroenterol; 1996 Aug; 91(8):1626-30. PubMed ID: 8759674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
    Rota Scalabrini D; Caravelli D; Carnevale Schianca F; D'Ambrosio L; Tolomeo F; Boccone P; Manca A; De Rosa G; Nuzzo A; Aglietta M; Grignani G
    BMC Res Notes; 2014 Aug; 7():529. PubMed ID: 25125318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.